UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000018217
Receipt number R000021085
Scientific Title A randomized phase II study to investigate the deepness of response of FOLFOXIRI plus cetuximab (Erbitux) versus FOLFOXIRI plus bevacizumab as the first-line therapy in metastatic colorectal cancer patients with RAS wild-type tumors: DEEPER
Date of disclosure of the study information 2015/07/15
Last modified on 2020/07/21 10:22:38

No. Disposal Last modified on Item of update
1 Insert 2015/07/06 17:00:17
2 Update 2016/11/15 13:57:37 Interventions/Control_1
Key inclusion criteria
3 Update 2016/11/15 13:58:08 Name of primary person or sponsor
Organization
Organization
4 Update 2016/11/15 13:59:51 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
5 Update 2020/07/21 10:19:43 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization1
Organization
Organization
Address
Address
Tel
Email
Institutions
6 Update 2020/07/21 10:22:12 Recruitment status
Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
7 Update 2020/07/21 10:22:38 Number of participants that the trial has enrolled